EOD dosing isn't a step backward
In another example, a 2023 report by market research firm Circana [1] , which tracks in-store purchases using scanner data purchased from retailers, found that GLP-1 users were scaling back purchases at a similar level to the average US household, with a marginal unit sales decline of 0.1% higher. The report did note, however, that households with a GLP-1 user were purchasing different items than non-GLP-1 households namely: high-protein, energy-boosting, hydration, and convenient snack products. GLP-1 medications have several side effects, including nausea and muscle loss
For breastfeeding women who require tirzepatide, starting at 2.5 mg and titrating slowly while monitoring milk supply and infant development represents the most conservative approach
Our legal team will evaluate whether your injuries may be linked to GLP-1 receptor agonist drugs, explain your legal options, and guide you through filing an individual lawsuit, joining a class action, or being included in multidistrict litigation